Showing results (301-310 of 318) with videos related to
Sort By:
Pageof 32
Journal of the American Heart Association|July 21, 2022
Effect of Incorporating 1 Avocado Per Day Versus Habitual Diet on Visceral Adiposity: A Randomized TrialAlice H Lichtenstein, Penny M Kris-Etherton, Kristina S Petersen, et al.Nature Communications|March 7, 2017
Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor geneMarcus Lefebure, Richard W Tothill, Elizabeth Kruse, et al.Science Signaling|October 5, 2017
Genome-wide functional analysis reveals central signaling regulators of lymphatic endothelial cell migration and remodelingSteven P Williams, Adam F Odell, Tara Karnezis, et al.Cancer Research|June 25, 2017
EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian CarcinomasDariush Etemadmoghadam, Walid J Azar, Ying Lei, et al.Nature Medicine|November 21, 2018
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphomaRishu Agarwal, Yih-Chih Chan, Constantine S Tam, et al.JCO Precision Oncology|February 17, 2022
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic MelanomaStephen Q Wong, Jeanette M Raleigh, Jason Callahan, et al.Chemical Science|January 13, 2022
Discovery of cell active macrocyclic peptides with on-target inhibition of KRAS signalingShuhui Lim, Nicolas Boyer, Nicole Boo, et al.Cancer Research|December 3, 2015
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell CarcinomasStephen Q Wong, Kelly Waldeck, Ismael A Vergara, et al.Current Opinion in Cardiology|May 26, 2026
Superficial intercostal plane blocks for post-sternotomy pain control rationale and design for the EPOCH CardioLink-10 randomized clinical trialNitish K Dhingra, Fallon Dennis, Syed Mohammad Ali Hassan, et al.Nature Cancer|June 5, 2023
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistanceThijs J Hagenbeek, Jason R Zbieg, Marc Hafner, et al.Pageof 32